Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Tuberculosis

Free Subscription Articles published in PLoS Med Retrieve available abstracts of 31 articles: HTML format

Single Articles

September 2021
1. MACPHERSON P, Webb EL, Kamchedzera W, Joekes E, et al
   Computer-aided X-ray screening for tuberculosis and HIV testing among adults with cough in Malawi (the PROSPECT study): A randomised trial and cost-effectiveness analysis.
   PLoS Med. 2021;18:e1003752.
   PubMed     Abstract available
   
   
   
2. BASTOS ML, Melnychuk L, Campbell JR, Oxlade O, et al
   The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis.
   PLoS Med. 2021;18:e1003703.
   PubMed     Abstract available
   
   
   
3. AULD AF, Kerkhoff AD, Hanifa Y, Wood R, et al
   Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort study.
   PLoS Med. 2021;18:e1003739.
   PubMed     Abstract available
   
   
   
4. UPPAL A, Rahman S, Campbell JR, Oxlade O, et al
   Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.
   PLoS Med. 2021;18:e1003712.
   PubMed     Abstract available
   
   
   
5. YANES-LANE M, Ortiz-Brizuela E, Campbell JR, Benedetti A, et al
   Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis.
   PLoS Med. 2021;18:e1003738.
   PubMed     Abstract available
   
   
   
6. OXLADE O, Rochon H, Campbell JR, Menzies D, et al
   Tuberculosis preventive treatment in people living with HIV-Is the glass half empty or half full?
   PLoS Med. 2021;18:e1003702.
   PubMed     Abstract available
   
   
   July 2021
7. YU S, Sohn H, Kim HY, Kim H, et al
   Evaluating the impact of the nationwide public-private mix (PPM) program for tuberculosis under National Health Insurance in South Korea: A difference in differences analysis.
   PLoS Med. 2021;18:e1003717.
   PubMed     Abstract available
   
   
   May 2021
8. CATTAMANCHI A, Crowder R, Kityamuwesi A, Kiwanuka N, et al
   Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in Uganda.
   PLoS Med. 2021;18:e1003628.
   PubMed     Abstract available
   
   
   April 2021
9. CALDERWOOD CJ, Wilson JP, Fielding KL, Harris RC, et al
   Dynamics of sputum conversion during effective tuberculosis treatment: A systematic review and meta-analysis.
   PLoS Med. 2021;18:e1003566.
   PubMed     Abstract available
   
   
   January 2021
10. DORJEE K, Topgyal S, Tsewang T, Tsundue T, et al
    Risk of developing active tuberculosis following tuberculosis screening and preventive therapy for Tibetan refugee children and adolescents in India: An impact assessment.
    PLoS Med. 2021;18:e1003502.
    PubMed     Abstract available
    
    
    December 2020
11. CILLONI L, Kranzer K, Stagg HR, Arinaminpathy N, et al
    Trade-offs between cost and accuracy in active case finding for tuberculosis: A dynamic modelling analysis.
    PLoS Med. 2020;17:e1003456.
    PubMed     Abstract available
    
    
    
12. RICKS S, Denkinger CM, Schumacher SG, Hallett TB, et al
    The potential impact of urine-LAM diagnostics on tuberculosis incidence and mortality: A modelling analysis.
    PLoS Med. 2020;17:e1003466.
    PubMed     Abstract available
    
    
    November 2020
13. BAIK Y, Rickman HM, Hanrahan CF, Mmolawa L, et al
    A clinical score for identifying active tuberculosis while awaiting microbiological results: Development and validation of a multivariable prediction model in sub-Saharan Africa.
    PLoS Med. 2020;17:e1003420.
    PubMed     Abstract available
    
    
    October 2020
14. KAVANAGH MM, Gostin LO, Stephens J
    Tuberculosis, human rights, and law reform: Addressing the lack of progress in the global tuberculosis response.
    PLoS Med. 2020;17:e1003324.
    PubMed     Abstract available
    
    
    September 2020
15. ABDULLAHI SA, Smelyanskaya M, John S, Adamu HI, et al
    Providing TB and HIV outreach services to internally displaced populations in Northeast Nigeria: Results of a controlled intervention study.
    PLoS Med. 2020;17:e1003218.
    PubMed     Abstract available
    
    
    August 2020
16. MASKEW M, Brennan AT, Fox MP, Vezi L, et al
    A clinical algorithm for same-day HIV treatment initiation in settings with high TB symptom prevalence in South Africa: The SLATE II individually randomized clinical trial.
    PLoS Med. 2020;17:e1003226.
    PubMed     Abstract available
    
    
    May 2020
17. BROGER T, Nicol MP, Szekely R, Bjerrum S, et al
    Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: A meta-analysis of individual in- and outpatient data.
    PLoS Med. 2020;17:e1003113.
    PubMed     Abstract available
    
    
    
18. DEO S, Singh S, Jha N, Arinaminpathy N, et al
    Predicting the impact of patient and private provider behavior on diagnostic delay for pulmonary tuberculosis patients in India: A simulation modeling study.
    PLoS Med. 2020;17:e1003039.
    PubMed     Abstract available
    
    
    
19. KUMAR GS, Wien SS, Phares CR, Slim W, et al
    Health profile of adult special immigrant visa holders arriving from Iraq and Afghanistan to the United States, 2009-2017: A cross-sectional analysis.
    PLoS Med. 2020;17:e1003118.
    PubMed     Abstract available
    
    
    February 2020
20. LIENHARDT C, Nunn A, Chaisson R, Vernon AA, et al
    Advances in clinical trial design: Weaving tomorrow's TB treatments.
    PLoS Med. 2020;17:e1003059.
    PubMed     Abstract available
    
    
    January 2020
21. DEAN AS, Zignol M, Cabibbe AM, Falzon D, et al
    Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data.
    PLoS Med. 2020;17:e1003008.
    PubMed     Abstract available
    
    
    
22. SULIS G, Pai M
    Isoniazid-resistant tuberculosis: A problem we can no longer ignore.
    PLoS Med. 2020;17:e1003023.
    PubMed     Abstract available
    
    
    December 2019
23. VERNON A, Fielding K, Savic R, Dodd L, et al
    The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials.
    PLoS Med. 2019;16:e1002884.
    PubMed     Abstract available
    
    
    October 2019
24. BROWNE SH, Umlauf A, Tucker AJ, Low J, et al
    Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trial.
    PLoS Med. 2019;16:e1002891.
    PubMed     Abstract available
    
    
    
25. BRIGDEN G, Nhung NV, Skrahina A, Ndjeka N, et al
    Advances in clinical trial design for development of new TB treatments-Translating international tuberculosis treatment guidelines into national strategic plans: Experiences from Belarus, South Africa, and Vietnam.
    PLoS Med. 2019;16:e1002896.
    PubMed    
    
    
    
26. XU Y, Cancino-Munoz I, Torres-Puente M, Villamayor LM, et al
    High-resolution mapping of tuberculosis transmission: Whole genome sequencing and phylogenetic modelling of a cohort from Valencia Region, Spain.
    PLoS Med. 2019;16:e1002961.
    PubMed     Abstract available
    
    
    September 2019
27. LIENHARDT C, Vernon AA, Cavaleri M, Nambiar S, et al
    Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance.
    PLoS Med. 2019;16:e1002915.
    PubMed     Abstract available
    
    
    August 2019
28. GUPTA A, Hughes MD, Garcia-Prats AJ, McIntire K, et al
    Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons.
    PLoS Med. 2019;16:e1002882.
    PubMed     Abstract available
    
    
    April 2019
29. HANRAHAN CF, Nonyane BAS, Mmolawa L, West NS, et al
    Contact tracing versus facility-based screening for active TB case finding in rural South Africa: A pragmatic cluster-randomized trial (Kharitode TB).
    PLoS Med. 2019;16:e1002796.
    PubMed     Abstract available
    
    
    
30. HUERGA H, Mathabire Rucker SC, Cossa L, Bastard M, et al
    Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/mul in 2 low-resource settings: A prospective observational study.
    PLoS Med. 2019;16:e1002792.
    PubMed     Abstract available
    
    
    March 2019
31. LIENHARDT C, Nahid P
    Advances in clinical trial design for development of new TB treatments: A call for innovation.
    PLoS Med. 2019;16:e1002769.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: